358 results on '"Kociolek, Larry K"'
Search Results
2. Resurgence of SARS-CoV-2 Delta after Omicron variant superinfection in an immunocompromised pediatric patient
3. Redefining Clostridioides difficile infection antibiotic response and clinical outcomes
4. Clostridioides difficile
5. Contributors
6. Clostridium innocuum: Microbiological and clinical characteristics of a potential emerging pathogen
7. Children's Hospital Resource Utilization During the 2022 Viral Respiratory Surge.
8. Coronary Artery Outcomes in Kawasaki Disease by Treatment Day Within 10 Days of Fever Onset.
9. Pneumonia outbreaks due to re-emergence of Mycoplasma pneumoniae
10. Severe Hepatitis in Pediatric Coronavirus Disease 2019
11. Correlation between restriction endonuclease analysis and PCR ribotyping for the identification of Clostridioides (Clostridium) difficile clinical strains
12. 711. High Prevalence of Positive Cell Cytotoxicity Neutralization Assay in Symptomatic and Asymptomatic Pediatric Oncologic Patients
13. Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions
14. Introduction to A Compendium of Strategies to Prevent Healthcare-Associated Infections In Acute-Care Hospitals: 2022 Updates
15. Clostridium difficile Whole Genome Sequencing Reveals Limited Transmission Among Symptomatic Children : A Single-Center Analysis
16. Comparative genomics analysis of Clostridium difficile epidemic strain DH/NAP11/106
17. Executive Summary: A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute-Care Hospitals: 2022 Updates
18. Seasonality in Respiratory Syncytial Virus Hospitalizations and Immunoprophylaxis
19. Mycoplasma pneumoniae: gone forever?
20. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition
21. Healthcare-associated Respiratory Syncytial Virus in Children’s Hospitals
22. Targeted Vaccine Messaging to Promote COVID-19 Vaccines for Children and Youth
23. Intestinal bile acids provide a surmountable barrier against C. difficile TcdB-induced disease pathogenesis
24. Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 Update
25. Strategies to Prevent Clostridioides Difficile Infections in Acute-Care Hospitals: 2022 Update
26. Response to: Treatment of (Recurrent) Clostridioides difficile Infections in Children and Adults
27. Ideal and Actual Impact of Rapid Diagnostic Testing and Antibiotic Stewardship on Antibiotic Prescribing and Clinical Outcomes in Children With Positive Blood Cultures
28. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition
29. Fecal Microbiota Transplantation for Clostridioides difficile Infection in Immunocompromised Pediatric Patients
30. Baseline stool toxin concentration is associated with risk of recurrence in children with Clostridioides difficile infection
31. Clostridioides difficile Infection in Hospitalized Pediatric Patients: Comparisons of Epidemiology, Testing, and Treatment from 2013 to 2019
32. Risk Factors for Recurrent Clostridium difficile Infection in Children: A Nested Case-Control Study
33. 221. Assessment and Proposed Revision of Clinical Trial Clostridioides difficile Infection Clinical Response and Outcomes Definitions
34. Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?
35. Incidence and Clinical Characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 Infection After Vaccination in Children
36. 883. Stool Toxin Concentrations Are Higher in Children with Baseline Severe Disease, Severe Outcomes, and Recurrence
37. Central venous catheter salvage in children with Staphylococcus aureus central line-associated bloodstream infection
38. Characteristics and Clinical Outcomes of Children and Adolescents Aged <18 Years Hospitalized with COVID-19 — Six Hospitals, United States, July–August 2021
39. Chicago Ebola Response Network (CERN): A Citywide Cross-hospital Collaborative for Infectious Disease Preparedness
40. 190 - Clostridioides difficile
41. Breakthroughs in the treatment and prevention of Clostridium difficile infection
42. Severity of Illness Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern in Children: A Single-Center Retrospective Cohort Study
43. Factors Associated With Severe Illness in Patients Aged <21 Years Hospitalized for COVID-19
44. Stool Toxin Concentration Does Not Distinguish Clostridioides difficile Infection from Colonization in Children Less Than 3 Years of Age
45. Association Between Clostridium innocuum and Antibiotic-Associated Diarrhea in Adults and Children: A Cross-sectional Study and Comparative Genomics Analysis
46. Pneumonia outbreaks due to re-emergence of Mycoplasma pneumoniae
47. Clostridium difficile infection and commonly used pediatric medications
48. Association Between Clostridium innocuum and Antibiotic-Associated Diarrhea in Adults and Children: A Cross-sectional Study and Comparative Genomics Analysis.
49. Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions
50. Concomitant Medical Conditions and Therapies Preclude Accurate Classification of Children With Severe or Severe Complicated Clostridium difficile Infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.